Cetuximab beta
Cetuximab beta, sold under the brand name Enlituo, is a monoclonal antibody used for the treatment of colorectal cancer.
≈ 1 min read
Cetuximab beta. encyclopegia.org, snapshot enwiki-001375602350. /a/cetuximab-beta
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Cetuximab beta, sold under the brand name Enlituo, is a monoclonal antibody used for the treatment of colorectal cancer. Cetuximab beta was approved for medical use in China in June 2024.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1375602350 under CC BY-SA 4.0; modifications have been made.